Enanta Pharmaceuticals Announces the Appointment of Timothy D. Ocain, Ph.D. as Senior Vice President, New Product Strategy and Development

04-02-2014 Business Wire HealthComments (0)

Enanta PharmaceuticalsPharmaceutical

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) today announced the appointment of Timothy D. Ocain, Ph.D. as Senior Vice President, New Product Strategy and Development. Dr. Ocain has over 25 years’ experience working in the pharmaceutical and biotechnology environment with experience in medicinal chemistry, pharmacology, biochemistry, program management and preclinical and early development across multiple therapeutic areas. He is co-author on over 30 publication

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top